Organon Shares Rally 16% in Premarket as Sun Pharma Announces Buyout
OGN stock soars as Sun Pharma strikes $11.75B all-cash deal, aiming to expand biosimilars reach and boost global pharma standing.
Open original sourceLoading market dashboard
OGN stock soars as Sun Pharma strikes $11.75B all-cash deal, aiming to expand biosimilars reach and boost global pharma standing.
Open original source